Endue

• Organizations that require SOC 2 Type II, HITRUST, or extensive published security controls prior to procurement
• Sites that require deeply proven integrations with a specific EMR/pharmacy/billing stack and multiple reference customers on that exact stack
• Buyers that require a substantial independent review footprint before considering a vendor

• Limited public documentation on security controls beyond high-level assertions.
• No public list pricing and limited module/suite detail.
• Minimal independent review footprint on major B2B review platforms; no verified Capterra reviews were present at the time of research.

• No detailed public roadmap was identified in the pages reviewed.

• Public court documents reference litigation with a competitor; the cited action was dismissed on jurisdictional grounds and was not a merits decision. Buyers concerned with vendor conduct or IP risk should include this in legal diligence.

• Reporting of a 2025 security incident is the most prominent public item; confirm the exact scope, clients involved, and remediation steps directly with the vendor during due diligence.

• End-to-end infusion workflow coverage (intake, scheduling, inventory, reporting) as described by the vendor
• Embedded messaging and notification capabilities to support team coordination
• Reported integrations with EMRs and pharmacy systems via API/HL7

• Scale and market presence: some competing vendors and partners present a broader footprints and partner validations that may reduce perceived vendor risk.

• Gartner Peer Insights: No Endue listing or reviews surfaced in accessible search results during this research.
• G2: No clear Endue product page with verified user reviews was identified in accessible results.
• TrustRadius: No Endue review page was found during the research.

• Capterra lists the vendor but showed no verified user reviews at the time of access, indicating a limited independent review corpus.

The vendor’s website contains brief testimonial snippets attributed to roles but not to named organizations or verifiable deployments. These excerpts generally reference improved reporting capabilities, faster patient scheduling, and customization/ease-of-use. Because these testimonials lack organizational attribution and measurable outcomes, they should not substitute for independent references.

• No substantive Endue-specific discussions were identified on Reddit or HackerNews in accessible searches. Broader community forums include general discussions about infusion/home-infusion software, but they do not provide Endue-specific evaluations.

• Structured intake and document handling (fax ingestion, splitting, reviews)
• Scheduling tailored to infusion operations (chair and medication-aware scheduling)
• Inventory management and forecasting
• Embedded team messaging and tasking

• Elevated vendor-risk concerns following publicly reported security incidents
• Preference for established incumbents with deeper billing/claims integrations or larger install bases
• Concerns about early-stage product maturity or vendor scale

No detailed case studies with named customers and quantified metrics were identified on the vendor pages.

The vendor asserts outcomes including cost reduction, faster patient initiation on therapy, and reduced reimbursement risk via prior authorization tracking. No methodology or independent ROI validation was provided in the materials reviewed.

Based on the vendor’s volume-based pricing approach, the practical ICP likely includes:

• Small to mid-sized infusion centers (ranging from lower-volume outpatient infusion sites up through larger-volume centers; vendor materials reference flexible volume-based pricing).

• Outpatient infusion centers across specialties (rheumatology, gastroenterology, neurology, immunology, oncology-adjacent infusion)
• Home infusion and specialty pharmacy operators

• Decision makers: Clinic/infusion operations leadership, revenue cycle leadership, pharmacy directors, and IT/security personnel for covered entities
• End users: Intake coordinators, prior authorization specialists, schedulers, infusion nurses, inventory/pharmacy staff, and managers

• Administrative burden (fax and document handling, prior authorization tracking)
• Scheduling throughput and utilization (chairs and medication-aware scheduling)
• Inventory forecasting and traceability
• Internal team coordination and messaging

Endue is a cloud-based infusion operations platform designed to manage patient and medication workflows for infusion centers and home infusion/specialty pharmacy operators. The platform covers intake, scheduling, inventory, and reporting in a single system and includes structured workflows and embedded internal communication tools to reduce administrative work.

• Primary buyers/users: Infusion operators, infusion centers, and home infusion pharmacies (US-focused).
• Positioning: The vendor presents the product as a purpose-built end-to-end infusion workflow platform covering intake, benefits checks/prior authorization, chair scheduling, inventory, and reporting.